GDF-11 Dosage & Reconstitution Guide
⚠ GDF-11's role is scientifically contested — 'young blood' rejuvenation claims were partly walked back, and it can be anti-regenerative in muscle. No human self-use protocol exists.
Research and educational use only — not medical advice, and not for human consumption. The figures below are summarized from public sources, product labeling, and community reports, and are not a prescription or a substitute for a qualified clinician.
Dosing schedule
The table below reports the doses used in the underlying research or by the community — it is documentation, not a recommendation to replicate at home.
| Phase | Dose | Notes |
|---|---|---|
| Animal / clinical-inhibitor work | 0.05 mg | 0.05–4.5 mg/kg ranges appear in trials, weight-scaled |
Timing & cycling
Animal studies used weight-scaled injection or infusion; there is no human schedule.
Cycle length. None established.
Storage & handling
Keep the lyophilized (unmixed) vial refrigerated at 2–8 °C (36–46 °F) in a dry, dark place — it tolerates short periods at room temperature during shipping. Once reconstituted, store it at 2–8 °C, never frozen, and use it within about 2–4 weeks (sooner if the solution turns cloudy or discolored). Swab the stopper before every draw and use a fresh needle each time.
Key points
- A TGF-β family member closely related to myostatin — which is why its effects on muscle are complicated rather than simply anabolic.
- Sold as a research chemical; the honest use case is in vitro, not in a person.
What to monitor
No home markers. Muscle effects in animals were dose-sensitive and sometimes negative.
Legal & prescription status
No legal prescription exists. It is an unapproved research chemical, sold only for laboratory research and labelled 'not for human consumption.' It is not FDA-approved for any human use.
References
This guide is for research and educational purposes only. It is not medical advice and does not describe a product approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.